B-cell linker
BLNK | |||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
Identifiers | |||||||||||||||||||||||||||||||||||||||||||||||||||
Aliases | BLNK, AGM4, BASH, BLNK-S, LY57, SLP-65, SLP65, bca, B-cell linker, B cell linker | ||||||||||||||||||||||||||||||||||||||||||||||||||
External IDs | OMIM: 604515; MGI: 96878; HomoloGene: 32038; GeneCards: BLNK; OMA:BLNK - orthologs | ||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
Wikidata | |||||||||||||||||||||||||||||||||||||||||||||||||||
|
B-cell linker (BLNK) protein is expressed in B cells and macrophages and plays a large role in B cell receptor signaling.[5] Like all adaptor proteins, BLNK has no known intrinsic enzymatic activity.[6] Its function is to temporally and spatially coordinate and regulate downstream signaling effectors in B cell receptor (BCR) signaling, which is important in B cell development.[7] Binding of these downstream effectors is dependent on BLNK phosphorylation.[8][9] BLNK is encoded by the BLNK gene[8][10] and is also known as SLP-65,[11] BASH,[12] and BCA.[13]
Structure and localization
[edit]BLNK consists of a N-terminal leucine zipper motif followed by an acidic region, a proline-rich region, and a C-terminal SH2 domain.[14][5] The leucine zipper motif allows BLNK to localize to the plasma membrane, presumably by coiled-coil interactions with a membrane protein.[5] This leucine zipper motif distinguishes BLNK from lymphoctye cytosolic protein 2, also known as LCP-2 or SLP-76, which plays a similar role in T cell receptor signaling.[15] Although LCP-2 has an N-terminal heptad-like organization of leucine and isoleucine residues like BLNK, it has not been experimentally shown to have the leucine zipper motif.[16] Recruitment of BLNK to the plasma membrane is also achieved by binding of the SH2 domain of BLNK to a non-ITAM phospho-tyrosine on the cytoplasmic domain of CD79A, which is a part of Igα and the B cell receptor complex.[17][18][19]
Function
[edit]BLNK's function and importance in B cell development were first illustrated in BLNK deficient DT40 cells, a chicken B cell line.[7] DT40 cells had interrupted B cell development: there was no calcium mobilization response in the B cell, impaired activation of the mitogen-activated protein (MAP) kinases p38, JNK, and somewhat inhibited ERK activation upon (BCR) activation as compared to wild type DT40 cells.[7] In knockout mice, BLNK deficiency results in a partial block in B cell development,[20][21] and in humans BLNK deficiency results in a much more profound block in B cell development.[22][5]
Linker or adaptor proteins provide mechanisms by which receptors can amplify and regulate downstream effector proteins.[6] BLNK is essential for normal B-cell development as part of the B cell receptor signaling pathway. [supplied by OMIM][10][23][24]
Evidence also suggests that BLNK may have tumor suppressive activity through its interaction with Bruton's tyrosine kinase (Btk) [25][26] and regulation of the pre-B cell checkpoint.[14][27]
Phosphorylation and interactions
[edit]The acidic region of BLNK contains several inducibly phosphorylated tyrosine residues, at least five of which are found in humans.[28] Evidence suggests that BLNK is phosphorylated by the tyrosine-protein kinase Syk after B cell receptor activation.[8][9][24][29] Phosphorylation of these residues provides docking sites necessary for downstream protein-protein interactions between BLNK and the SH2 domain-containing proteins Grb2,[8][11][17][30] PLCG2, Btk, the Vav protein family, and Nck.[31][9][8] BLNK has also been shown to interact with SH3KBP1[32] and MAP4K1.[33] A more recent mass spectrometry study of BLNK in DT40 cells found that at least 41 unique serine, threonine, and tyrosine residues are phosphorylated on BLNK.[34]
References
[edit]- ^ a b c GRCh38: Ensembl release 89: ENSG00000095585 – Ensembl, May 2017
- ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000061132 – Ensembl, May 2017
- ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ a b c d Köhler F, Storch B, Kulathu Y, Herzog S, Kuppig S, Reth M, Jumaa H (February 2005). "A leucine zipper in the N terminus confers membrane association to SLP-65". Nature Immunology. 6 (2): 204–210. doi:10.1038/ni1163. PMID 15654340. S2CID 10708737.
- ^ a b Borowicz P, Chan H, Hauge A, Spurkland A (November 2020). "Adaptor proteins: Flexible and dynamic modulators of immune cell signalling". Scandinavian Journal of Immunology. 92 (5): e12951. doi:10.1111/sji.12951. hdl:10852/82328. PMID 32734639. S2CID 220892370.
- ^ a b c Ishiai M, Kurosaki M, Pappu R, Okawa K, Ronko I, Fu C, et al. (January 1999). "BLNK required for coupling Syk to PLC gamma 2 and Rac1-JNK in B cells". Immunity. 10 (1): 117–125. doi:10.1016/S1074-7613(00)80012-6. PMID 10023776.
- ^ a b c d e Fu C, Turck CW, Kurosaki T, Chan AC (July 1998). "BLNK: a central linker protein in B cell activation". Immunity. 9 (1): 93–103. doi:10.1016/S1074-7613(00)80591-9. PMID 9697839.
- ^ a b c Hong JJ, Yankee TM, Harrison ML, Geahlen RL (August 2002). "Regulation of signaling in B cells through the phosphorylation of Syk on linker region tyrosines. A mechanism for negative signaling by the Lyn tyrosine kinase". The Journal of Biological Chemistry. 277 (35): 31703–31714. doi:10.1074/jbc.M201362200. PMID 12077122.
- ^ a b "Entrez Gene: BLNK B-cell linker".
- ^ a b Wienands J, Schweikert J, Wollscheid B, Jumaa H, Nielsen PJ, Reth M (August 1998). "SLP-65: a new signaling component in B lymphocytes which requires expression of the antigen receptor for phosphorylation". The Journal of Experimental Medicine. 188 (4): 791–795. doi:10.1084/jem.188.4.791. PMC 2213353. PMID 9705962.
- ^ Goitsuka R, Fujimura Y, Mamada H, Umeda A, Morimura T, Uetsuka K, et al. (December 1998). "BASH, a novel signaling molecule preferentially expressed in B cells of the bursa of Fabricius". Journal of Immunology. 161 (11): 5804–5808. doi:10.4049/jimmunol.161.11.5804. PMID 9834055. S2CID 38459642.
- ^ Gangi-Peterson L, Peterson SN, Shapiro LH, Golding A, Caricchio R, Cohen DI, et al. (January 1998). "bca: an activation-related B-cell gene". Molecular Immunology. 35 (1): 55–63. doi:10.1016/s0161-5890(98)00008-x. PMID 9683264.
- ^ a b Herzog S, Storch B, Jumaa H (2006). "Dual role of the adaptor protein SLP-65: organizer of signal transduction and tumor suppressor of pre-B cell leukemia". Immunologic Research. 34 (2): 143–155. doi:10.1385/ir:34:2:143. PMID 16760574. S2CID 11515343.
- ^ Koretzky GA, Abtahian F, Silverman MA (January 2006). "SLP76 and SLP65: complex regulation of signalling in lymphocytes and beyond". Nature Reviews. Immunology. 6 (1): 67–78. doi:10.1038/nri1750. PMID 16493428. S2CID 22368341.
- ^ Rudd CE, Raab M (April 2003). "Independent CD28 signaling via VAV and SLP-76: a model for in trans costimulation". Immunological Reviews. 192 (1): 32–41. doi:10.1034/j.1600-065X.2003.00005.x. PMID 12670393. S2CID 33990866.
- ^ a b Engels N, Wollscheid B, Wienands J (July 2001). "Association of SLP-65/BLNK with the B cell antigen receptor through a non-ITAM tyrosine of Ig-alpha". European Journal of Immunology. 31 (7): 2126–2134. doi:10.1002/1521-4141(200107)31:7<2126::AID-IMMU2126>3.0.CO;2-O. PMID 11449366. S2CID 31494726.
- ^ Kabak S, Skaggs BJ, Gold MR, Affolter M, West KL, Foster MS, et al. (April 2002). "The direct recruitment of BLNK to immunoglobulin alpha couples the B-cell antigen receptor to distal signaling pathways". Molecular and Cellular Biology. 22 (8): 2524–2535. doi:10.1128/MCB.22.8.2524-2535.2002. PMC 133735. PMID 11909947.
- ^ Pike KA, Ratcliffe MJ (February 2005). "Dual requirement for the Ig alpha immunoreceptor tyrosine-based activation motif (ITAM) and a conserved non-Ig alpha ITAM tyrosine in supporting Ig alpha beta-mediated B cell development". Journal of Immunology. 174 (4): 2012–2020. doi:10.4049/jimmunol.174.4.2012. PMID 15699130.
- ^ Jumaa H, Wollscheid B, Mitterer M, Wienands J, Reth M, Nielsen PJ (November 1999). "Abnormal development and function of B lymphocytes in mice deficient for the signaling adaptor protein SLP-65". Immunity. 11 (5): 547–554. doi:10.1016/S1074-7613(00)80130-2. PMID 10591180.
- ^ Pappu R, Cheng AM, Li B, Gong Q, Chiu C, Griffin N, et al. (December 1999). "Requirement for B cell linker protein (BLNK) in B cell development". Science. 286 (5446): 1949–1954. doi:10.1126/science.286.5446.1949. PMID 10583957.
- ^ Minegishi Y, Rohrer J, Coustan-Smith E, Lederman HM, Pappu R, Campana D, et al. (December 1999). "An essential role for BLNK in human B cell development". Science. 286 (5446): 1954–1957. doi:10.1126/science.286.5446.1954. PMID 10583958.
- ^ Wang LD, Clark MR (December 2003). "B-cell antigen-receptor signalling in lymphocyte development". Immunology. 110 (4): 411–420. doi:10.1111/j.1365-2567.2003.01756.x. PMC 1783068. PMID 14632637. S2CID 40885940.
- ^ a b Murphy K (2012). Janeway's immunobiology. Paul Travers, Mark Walport, Charles Janeway (8th ed.). New York: Garland Science. ISBN 978-0-8153-4243-4. OCLC 733935898.
- ^ Yasuda T, Tezuka T, Maeda A, Inazu T, Yamanashi Y, Gu H, et al. (July 2002). "Cbl-b positively regulates Btk-mediated activation of phospholipase C-gamma2 in B cells". The Journal of Experimental Medicine. 196 (1): 51–63. doi:10.1084/jem.20020068. PMC 2194016. PMID 12093870.
- ^ Hashimoto S, Iwamatsu A, Ishiai M, Okawa K, Yamadori T, Matsushita M, et al. (October 1999). "Identification of the SH2 domain binding protein of Bruton's tyrosine kinase as BLNK--functional significance of Btk-SH2 domain in B-cell antigen receptor-coupled calcium signaling". Blood. 94 (7): 2357–2364. doi:10.1182/blood.V94.7.2357.419k40_2357_2364. PMID 10498607. S2CID 21014231.
- ^ Hendriks RW, Kersseboom R (February 2006). "Involvement of SLP-65 and Btk in tumor suppression and malignant transformation of pre-B cells". Seminars in Immunology. 18 (1): 67–76. doi:10.1016/j.smim.2005.10.002. PMID 16300960.
- ^ "BLNK B cell linker [Homo sapiens (human)] - Gene - NCBI". www.ncbi.nlm.nih.gov. Retrieved 2023-03-07.
- ^ Geahlen RL (July 2009). "Syk and pTyr'd: Signaling through the B cell antigen receptor". Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1793 (7): 1115–1127. doi:10.1016/j.bbamcr.2009.03.004. PMC 2700185. PMID 19306898.
- ^ Fusaki N, Tomita S, Wu Y, Okamoto N, Goitsuka R, Kitamura D, Hozumi N (May 2000). "BLNK is associated with the CD72/SHP-1/Grb2 complex in the WEHI231 cell line after membrane IgM cross-linking". European Journal of Immunology. 30 (5): 1326–1330. doi:10.1002/(SICI)1521-4141(200005)30:5<1326::AID-IMMU1326>3.0.CO;2-Q. PMID 10820378.
- ^ Chiu CW, Dalton M, Ishiai M, Kurosaki T, Chan AC (December 2002). "BLNK: molecular scaffolding through 'cis'-mediated organization of signaling proteins". The EMBO Journal. 21 (23): 6461–6472. doi:10.1093/emboj/cdf658. PMC 136961. PMID 12456653.
- ^ Watanabe S, Take H, Takeda K, Yu ZX, Iwata N, Kajigaya S (November 2000). "Characterization of the CIN85 adaptor protein and identification of components involved in CIN85 complexes". Biochemical and Biophysical Research Communications. 278 (1): 167–174. doi:10.1006/bbrc.2000.3760. PMID 11071869.
- ^ Tsuji S, Okamoto M, Yamada K, Okamoto N, Goitsuka R, Arnold R, et al. (August 2001). "B cell adaptor containing src homology 2 domain (BASH) links B cell receptor signaling to the activation of hematopoietic progenitor kinase 1". The Journal of Experimental Medicine. 194 (4): 529–539. doi:10.1084/jem.194.4.529. PMC 2193495. PMID 11514608.
- ^ Oellerich T, Grønborg M, Neumann K, Hsiao HH, Urlaub H, Wienands J (July 2009). "SLP-65 phosphorylation dynamics reveals a functional basis for signal integration by receptor-proximal adaptor proteins". Molecular & Cellular Proteomics. 8 (7): 1738–1750. doi:10.1074/mcp.M800567-MCP200. PMC 2709198. PMID 19372136.
Further reading
[edit]- Maruyama K, Sugano S (January 1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene. 138 (1–2): 171–174. doi:10.1016/0378-1119(94)90802-8. PMID 8125298.
- Fu C, Chan AC (October 1997). "Identification of two tyrosine phosphoproteins, pp70 and pp68, which interact with phospholipase Cgamma, Grb2, and Vav after B cell antigen receptor activation". The Journal of Biological Chemistry. 272 (43): 27362–27368. doi:10.1074/jbc.272.43.27362. PMID 9341187.
- Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, Suyama A, Sugano S (October 1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene. 200 (1–2): 149–156. doi:10.1016/S0378-1119(97)00411-3. PMID 9373149.
- Wienands J, Schweikert J, Wollscheid B, Jumaa H, Nielsen PJ, Reth M (August 1998). "SLP-65: a new signaling component in B lymphocytes which requires expression of the antigen receptor for phosphorylation". The Journal of Experimental Medicine. 188 (4): 791–795. doi:10.1084/jem.188.4.791. PMC 2213353. PMID 9705962.
- Hashimoto S, Iwamatsu A, Ishiai M, Okawa K, Yamadori T, Matsushita M, et al. (October 1999). "Identification of the SH2 domain binding protein of Bruton's tyrosine kinase as BLNK--functional significance of Btk-SH2 domain in B-cell antigen receptor-coupled calcium signaling". Blood. 94 (7): 2357–2364. doi:10.1182/blood.V94.7.2357.419k40_2357_2364. PMID 10498607. S2CID 21014231.
- Su YW, Zhang Y, Schweikert J, Koretzky GA, Reth M, Wienands J (November 1999). "Interaction of SLP adaptors with the SH2 domain of Tec family kinases". European Journal of Immunology. 29 (11): 3702–3711. doi:10.1002/(SICI)1521-4141(199911)29:11<3702::AID-IMMU3702>3.0.CO;2-R. PMID 10556826.
- Fusaki N, Tomita S, Wu Y, Okamoto N, Goitsuka R, Kitamura D, Hozumi N (May 2000). "BLNK is associated with the CD72/SHP-1/Grb2 complex in the WEHI231 cell line after membrane IgM cross-linking". European Journal of Immunology. 30 (5): 1326–1330. doi:10.1002/(SICI)1521-4141(200005)30:5<1326::AID-IMMU1326>3.0.CO;2-Q. PMID 10820378.
- Mizuno K, Tagawa Y, Mitomo K, Arimura Y, Hatano N, Katagiri T, et al. (August 2000). "Src homology region 2 (SH2) domain-containing phosphatase-1 dephosphorylates B cell linker protein/SH2 domain leukocyte protein of 65 kDa and selectively regulates c-Jun NH2-terminal kinase activation in B cells". Journal of Immunology. 165 (3): 1344–1351. doi:10.4049/jimmunol.165.3.1344. PMID 10903736.
- Guo B, Kato RM, Garcia-Lloret M, Wahl MI, Rawlings DJ (August 2000). "Engagement of the human pre-B cell receptor generates a lipid raft-dependent calcium signaling complex". Immunity. 13 (2): 243–253. doi:10.1016/S1074-7613(00)00024-8. PMID 10981967.
- Watanabe S, Take H, Takeda K, Yu ZX, Iwata N, Kajigaya S (November 2000). "Characterization of the CIN85 adaptor protein and identification of components involved in CIN85 complexes". Biochemical and Biophysical Research Communications. 278 (1): 167–174. doi:10.1006/bbrc.2000.3760. PMID 11071869.
- Tan JE, Wong SC, Gan SK, Xu S, Lam KP (June 2001). "The adaptor protein BLNK is required for b cell antigen receptor-induced activation of nuclear factor-kappa B and cell cycle entry and survival of B lymphocytes". The Journal of Biological Chemistry. 276 (23): 20055–20063. doi:10.1074/jbc.M010800200. PMID 11274146.
- Adachi T, Wienands J, Wakabayashi C, Yakura H, Reth M, Tsubata T (July 2001). "SHP-1 requires inhibitory co-receptors to down-modulate B cell antigen receptor-mediated phosphorylation of cellular substrates". The Journal of Biological Chemistry. 276 (28): 26648–26655. doi:10.1074/jbc.M100997200. PMID 11356834.
- Engels N, Wollscheid B, Wienands J (July 2001). "Association of SLP-65/BLNK with the B cell antigen receptor through a non-ITAM tyrosine of Ig-alpha". European Journal of Immunology. 31 (7): 2126–2134. doi:10.1002/1521-4141(200107)31:7<2126::AID-IMMU2126>3.0.CO;2-O. PMID 11449366. S2CID 31494726.
- Sauer K, Liou J, Singh SB, Yablonski D, Weiss A, Perlmutter RM (November 2001). "Hematopoietic progenitor kinase 1 associates physically and functionally with the adaptor proteins B cell linker protein and SLP-76 in lymphocytes". The Journal of Biological Chemistry. 276 (48): 45207–45216. doi:10.1074/jbc.M106811200. PMID 11487585.
- Engels N, Merchant M, Pappu R, Chan AC, Longnecker R, Wienands J (August 2001). "Epstein-Barr virus latent membrane protein 2A (LMP2A) employs the SLP-65 signaling module". The Journal of Experimental Medicine. 194 (3): 255–264. doi:10.1084/jem.194.3.255. PMC 2193464. PMID 11489945.
- Tsuji S, Okamoto M, Yamada K, Okamoto N, Goitsuka R, Arnold R, et al. (August 2001). "B cell adaptor containing src homology 2 domain (BASH) links B cell receptor signaling to the activation of hematopoietic progenitor kinase 1". The Journal of Experimental Medicine. 194 (4): 529–539. doi:10.1084/jem.194.4.529. PMC 2193495. PMID 11514608.
- Kabak S, Skaggs BJ, Gold MR, Affolter M, West KL, Foster MS, et al. (April 2002). "The direct recruitment of BLNK to immunoglobulin alpha couples the B-cell antigen receptor to distal signaling pathways". Molecular and Cellular Biology. 22 (8): 2524–2535. doi:10.1128/MCB.22.8.2524-2535.2002. PMC 133735. PMID 11909947.
- Yasuda T, Tezuka T, Maeda A, Inazu T, Yamanashi Y, Gu H, et al. (July 2002). "Cbl-b positively regulates Btk-mediated activation of phospholipase C-gamma2 in B cells". The Journal of Experimental Medicine. 196 (1): 51–63. doi:10.1084/jem.20020068. PMC 2194016. PMID 12093870.
External links
[edit]- Human BLNK genome location and BLNK gene details page in the UCSC Genome Browser.